Rate Notice: 5.9% general rate increase Jan 1, 2026 — Learn More
    UNIS logo
    The AstraZeneca logo featuring a blue and white triangle represents the pharmaceutical companys brand identity

    Astrazeneca Pharmaceuticals Lp

    AstraZeneca Pharmaceuticals LP is a global, science-led biopharmaceutical company specializing in innovative prescription medicines and serving millions of patients worldwide.

    Company Overview

    AstraZeneca is a leading multinational pharmaceutical and biotechnology company focused on the research, development, and commercialization of prescription medicines. The company operates across major therapeutic areas including oncology, cardiovascular, renal, metabolism, respiratory, and immunology. With a global workforce and operations in over 85 countries, AstraZeneca is recognized for its commitment to scientific excellence and patient outcomes.

    Key Metrics

    12,000

    Import Shipments

    20

    Distribution Centers

    45.0B

    Annual Revenue

    1999

    Founded

    Company Profile

    Key Milestones

    Important company milestones and achievements.

    Markets Served

    Geographic markets and customer segments served.

    Ownership Structure

    Corporate ownership and organizational structure.

    Sales Channels

    Distribution networks and sales approaches.

    Recent Developments

    AstraZeneca has recently focused on expanding its oncology portfolio, advancing digital health initiatives, and strengthening global supply chain resilience.

    Strategic Expansion

    Launch of new targeted therapies in oncology and rare diseases

    Market Expansion

    Strategic efforts to expand market presence and reach new customer segments.

    Technology Adoption

    Implementation of advanced technologies to improve service delivery and customer experience.

    Business Information

    AstraZeneca Pharmaceuticals LP develops, manufactures, and markets a broad portfolio of innovative medicines targeting complex diseases. The company is renowned for its contributions to oncology, cardiovascular, respiratory, and immunology treatments, as well as its pivotal role in developing the COVID-19 vaccine. AstraZeneca maintains strategic research centers in Cambridge (UK), Gothenburg (Sweden), and Gaithersburg (Maryland, US), supporting its global reach and scientific leadership. Its products are distributed in more than 130 countries, making it one of the largest pharmaceutical companies worldwide.

    Headquarters

    Cambridge, United Kingdom

    Founded

    1999

    Stock Symbol

    AZN